CD4 Cell Counts, Lipid Profile, and Oral Manifestations in HIV-Infected and AIDS Patients

  • Koduri Sridevi Department of Oral Medicine and Radiology, Lenora Institute of Dental Sciences, Rajahmundry, Andhra Pradesh, India
  • Saka Malathi Department of Oral Medicine and Radiology, Army College of Dental Sciences, Secunderabad, Telangana, India
  • Chalapathi KV Department of Oral Pathology and Microbiology, Care Dental College and Hospital, Guntur, Andhra Pradesh, India
  • Chowdary Nagarjuna G Department of Pedodontics and Preventive Dentistry, MNR Dental College and Hospital, Sangareddy, Telangana, India
  • M Gayathri Department of Oral Medicine and Radiology, Adhiparasakthi Dental College and Hospital, Melmaruvathur, Tamilnadu, India
  • G Eswar Chand Medical Graduate, Mamata Medical College, Khammam, Telangana, India
  • Abhishek Singh Nayyar Department of Oral Medicine and Radiology, Saraswati Dhanwantari Dental College and Hospital and Post-graduate Research Institute, Parbhani, Maharashtra, India
Keywords:
CD4 Cell Counts, Lipids, Oral Manifestations, HIV Infections, Acquired Immunodeficiency Syndrome

Abstract

Objectives: The present study aimed to evaluate CD4 cell counts, lipid profile, and oral manifestations in human immunodeficiency virus (HIV)-infected and acquired immune deficiency syndrome (AIDS) patients and their correlation with seronegative controls.

Materials and Methods: In this cross-sectional, hospital-based study, there were three groups of subjects: group A consisting of 500 healthy patients (controls), group B composed of 500 HIV-infected patients, and group C comprised of 500 AIDS patients based on their CD4 cell counts. CD4 cell counts were assessed using the CyFlow counter. Lipid profile was evaluated with the Erba EM 360 analyzer.

Results: The results were statistically significant for CD4 cell counts (P<0.001). The levels of total cholesterol (TC) and low-density lipoproteins (LDLs) were significantly decreased while triglycerides (TGs) and very-low-density lipoproteins (VLDLs) were significantly increased in AIDS patients compared to the controls and HIV-infected patients. Various results were obtained regarding oral manifestations with different levels of significance.

Conclusion: CD4 cell counts, TC, LDLs, TGs, and VLDLs were significantly changed in HIV-infected and AIDS patients compared to the controls.

References

References:

Khiangte L, Vidyabati RK, Singh MK, Devi SB, Singh TR, Singh WG. A Study of Serum Lipid Profile in Human Immunodeficiency Virus (HIV) Infected Patients. J Indian Acad Clin Med 2007;8:307-11.

Human immunodeficiency virus: AIDS. Ananthanarayan and Paniker's Textbook of Microbiology. 7th edition. New Delhi: Universities Press.

Abbas AK. Diseases of immunity. Robbins & Cotran Pathologic Basis of Disease. 7th edition. Philadelphia: Elsevier Saunders; 2005.

HIV sentinels surveillance: 2010-11. National AIDS Control Organization.

Fauci AS, Lane HC. Human immunodeficiency disease (HIV): AIDS and related disorders. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s Principle of Internal Medicine. 15th edition. McGraw-Hill Professional Publishing.

Abhinandan HB, Jain SK, Nyati A, Kumar R, Jain M, Bhuria J, et al. Cutaneous manifestations of HIV-infection in relation with CD4 cell counts in Hadoti Region. J Evol Med Dent Sci 2013;2:7003-14.

National Agency for the Control of AIDS. 2012. Abuja, Nigeria.

HIV sentinels surveillance: 2012-13. National AIDS Control Organization.

Sharma G, Pai MK, Nagpal A. Prevalence of Oral Manifestations and Their Association with CD4/CD8 Ratio and HIV Viral Load in South India. Int J Dent 2011;Article ID 964278.

Kiran K, Shetty S. Oral and periodontal manifestations among HIV population in Southern India. Int J Basic Applied Med Sci 2013;3:184-9.

Adurogbangba MI, Aderinokun GA, Odaibo GN, Olaleye OD, Lawoyin TO. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria.. Oral Dis 2004;10:319-26.

Pranitha SS, Kulkarni MH. Hematological changes in HIV infection with correlation to CD4 cell count. Aust Med J 2012;5:157-62.

Chanarat N, Chanarat P, Viratsethasin K, Suttajit M, Chiewsilp D. Biochemical and hematological manifestations of HIV/AIDS in Chiang Mai, Thailand. Southeast Asian J Trop Med Public Health 2001;32:500-3.

Ghate MV, Mehendale SM, Mahajan BA, Yadav R, Brahme RG, Divekar AD, et al. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India. Natl Med J India 2000;13:183-7.

Pasupathi P, Manivannan P, Manivannan U, Mathiyalagan D. Thyroid function, cardiac risk assessment profile and hematological changes during HIV infection and AIDS patients. J Medi 2010;11:131-6.

Srirangaraj S, Venkatesha D . Absolute lymphocyte count as a surrogate marker for CD4 counts after six months of HAART initiation in a resource limited setting in India. Indian J Med Res 2012;135:895-900.

Ana Luiza Dias Angelo, Camila Dias Angelo, Alex José Leite Torres, André Maurício Costa Ramos, Márcia Lima, Eduardo Martins Netto, Carlos Brites, et al. Evaluating total lymphocyte counts as a substitute for CD4 counts in the follow-up of AIDS patients. Braz J Infect Dis 2007;11:466-70.

Tiwari BR, Ghimire P, Malla S. Study on CD4 cell responses in HIV. Nepal Med Coll J 2008;10:45-7.

Dora Mbanya, Felix Assah, Nicaise Ndembi, Lazare Kaptue. Monitoring anti-retroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? I J Infect Dis 2007;11:157-60.

Sen S, Vyas A, Sanghi S, Shanmuganandan K, Gupta RM, Kapila K, et al. Correlation of CD4+ T cell Count with Total Lymphocyte Count, Hemoglobin and Erythrocyte Sedimentation Rate Levels in Human Immunodeficiency Virus Type-l Disease. MJAFI 2011;67:15-20.

Edathodu J, Ali B, Alrajhi AA. CD4 validation for the World Health Organization classification and clinical staging of HIV/AIDS in a developing country. Int J Infect Dis 2009;13:243-6.

Pasupathi P, Bakthavathsalam G, Saravanan G, Devaraj A. Changes in CD4 cell count, lipid profile and liver enzymes in HIV infection and AIDS patients. J of Appl Biomed 2008;6:139-45.

Sharma YK, Sawhney MPS, Bhakuni DS, Gera V. Oro-cutaneous manifestations as markers of disease progression in HIV infection in Indian setting. Med J Armed Forces India 2004;60:239-43.

Max Weyler Nery, Celina Maria Turchi Martelli, Marília Dalva Turchi. Dyslipidemia in AIDS patients on highly active anti-retroviral therapy. Braz J Infect Dis 2011;15:151-5.

Anastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA, et al. Association of serum lipid levels with HIV sero-status, specific anti-retroviral agents and treatment regimens. J Acquir Immune Defic Syndr 2007;45:34-42.

Adewole OO, Eze S, Betiku Y, Anteyi E, Wada I, Ajuwon Z, Erhabor G. Lipid profile in HIV/AIDS patients in Nigeria. J Afr Health Sci 2010;10:144-9.

Grunfeld C. Dyslipidemia and Its Treatment in HIV Infection. Topics in HIV Medicine 2010;18:112-8.

Shor-Posner G, Basit A, Lu Y, Cabrejos C, Chang J, Fletcher M, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 1993;94:515-9.

Pasupathi P, Ramachandran T, Sindhu P, Saravanan G, Bakthavathsalam G. Enhanced oxidative stress markers and antioxidant imbalance in HIV infection and AIDS patients. J Sci Res 2009;1:370–80.

Suelen Jorge Souza, Liania Alves Luzia, Sigrid Sousa Santos, Patrica Helen. Lipid profile of HIV infected patients in relation to anti-retroviral therapy: A review. Rev Assoc Med Bras 2013;59:186-98.

Agbelusi GA, Wright AA. Oral lesions as indicators of HIV infection among routine dental patients in Lagos, Nigeria. Oral Dis 2005;11:370-3.

Young J, Weber R, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, et al. Lipid profiles for anti-retroviral naive patients starting PI- and NN-RTI based therapy in the Swiss HIV cohort study. Antivir Ther 2005;10:585-91.

Crook M. The basis and management of metabolic abnormalities associated with cardiovascular risk in Human Immunodeficiency Virus infection and its treatment. Ann Clin Biochem 2007;44:219-31.

Pynka ML, Bauder D, Pynka S, Boron-Kaizmarsk. HIV/AIDS. HIV/AIDS Rev 2004;2:35-8.

TS Iffen, H Efobi, CAO Usoro, NE Udonwa. Lipid profile of HIV positive patients attending University of Calabar Teaching Hospital, Nigeria. World J Med Sci 2010;5:89-93.

El- Sadir WM. Effects of HIV Disease on Lipid, Glucose and Insulin Levels: Results from a Large Anti-retroviral naive Cohort. HIV Medicine 2005;6:114-21.

Akpa MR, Agomouh DI, Alasia DD. Lipid profile of healthy adult Nigerians in Port Harcourt, Nigeria. Niger J Med 2006;15:137-40.

Rogowska-Szadkowska D, Borzuchowska A. The levels of triglycerides, total cholesterol and HDL cholesterol in various stages of human immunodeficiency virus (HIV) infection. Pol Arch Med Wewn 1999;101:145-50.

Ducobu J, Payen MC. Lipids and AIDS. Rev Med Brux 2000;21:11-7.

Crook MA, Mir N. Abnormal lipids and the acquired immune deficiency syndrome is there a problem and what should we do about it. Int J STD AIDS 1999;10:353-6.

Published
2020-06-24
How to Cite
1.
Sridevi K, Malathi S, KV C, Nagarjuna G C, Gayathri M, Chand GE, Nayyar A. CD4 Cell Counts, Lipid Profile, and Oral Manifestations in HIV-Infected and AIDS Patients. Front Dent. 16(6):436-449.
Section
Original Article